Johannes Waltenberger

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Topics

Oral Anticoagulants

Atrial Fibrillation

Coronavirus Disease

Top Venues

Cardiovascular research

European heart journal

Cellular and molecular life sciences : CMLS

JMIR medical informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Arbustini Eloisa, Elijah R Behr, Lucie Carrier, Cornelia M Van Duijn, Paul Evans, Valentina Favalli, Pim van der Harst, Kristina Hermann Haugaa, Guillaume Jondeau, Stefan Kääb, Juan Pablo Pablo Kaski, Maryam Kavousi, Bart L Loeys, Antonis Pantazis, Yigal Pinto, Heribert Schunkert, Alessandro Di Toro, Thomas Thum, Mario Urtis, Johannes Waltenberger, Perry Mark Elliott
Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics. European heart journal 43 (20) (2022)
Paul C Evans, Sean M Davidson, Johann Wojta, Magnus Bäck, Sveva Bollini, Mairi Brittan, Alberico Luigi Catapano, Bill Chaudhry, Matthijs Cluitmans, Massimiliano Gnecchi, Tomasz J Guzik, Imo Hoefer, Rosalinda Madonna, João P Monteiro, Henning Morawietz, Elena Osto, Teresa Padró, Judith C Sluimer, Carlo Gabriele Tocchetti, Kim van der Heiden, Gemma Vilahur, Johannes Waltenberger, Christian Weber
From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22. Cardiovascular research 118 (13) (2022)
Péter Ferdinandy, Ákos Koller, Christian Weber, Johann Wojta, Johannes Waltenberger
Frontiers in CardioVascular Biomedicine (FCVB) 2022 Budapest is on in person! The excellent programme proves that scientists won against COVID-19. Cardiovascular research 118 (8) (2022)
Paulus F Kirchhof, Ladislav Pecen, Ameet Bakhai, Carlo de Asmundis, Joris R de Groot, Jean Claude Deharo, Peter Kelly, Pierre Levy, Esteban Lopez-de-Sa, Pedro Monteiro, Jan Steffel, Johannes Waltenberger, Thomas W Weiss, Petra Laeis, Marius Constantin Manu, José Souza, Raffaele De Caterina
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care. European heart journal. Cardiovascular pharmacotherapy (2022)
Sean M Davidson, Teresa Padró, Sveva Bollini, Gemma Vilahur, Dirk Jan Duncker, Paul C Evans, Tomasz Guzik, Imo E Hoefer, Johannes Waltenberger, Johann Wojta, Christian Weber
Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart. Cardiovascular research 117 (10) (2021)
Paul C Evans, Johann Wojta, Imo E Hoefer, Johannes Waltenberger, Tomasz Guzik, Lina Badimón, Christian Weber
The year in basic vascular biology research: from mechanoreceptors and neutrophil extracellular traps to smartphone data and omics. Cardiovascular research 117 (8) (2021)
Ralph Toelg, Ton Slagboom, Johannes Waltenberger, Thierry Lefèvre, Shigeru Saito, David E Kandzari, Jacques Koolen, Gert Richardt
Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 98 (5) (2020)
Markus Kentgen, Julian Varghese, Alexander Samol, Johannes Waltenberger, Martin Dugas
Common Data Elements for Acute Coronary Syndrome: Analysis Based on the Unified Medical Language System. JMIR medical informatics 7 (3) (2019)
Marina Dunaeva, Johannes Waltenberger
Hh signaling in regeneration of the ischemic heart. Cellular and molecular life sciences : CMLS 74 (19) (2017)